Recent Price Movement and Market Context
On 21 July 2026, Poly Medicure closed at ₹1,721.55, marking a 2.45% increase from the previous close of ₹1,680.45. The intraday range saw a low of ₹1,663.25 and a high of ₹1,730.00, indicating moderate volatility. The stock remains well below its 52-week high of ₹2,143.60 but comfortably above its 52-week low of ₹1,184.00, suggesting a recovery phase after a period of weakness.
Comparatively, Poly Medicure has outperformed the Sensex over the short and medium term. The stock posted a 4.45% return over the past week against the Sensex’s 0.12%, and a robust 10.18% gain over the last month compared to the Sensex’s 1.18%. However, year-to-date returns show a modest decline of 3.05%, though this is less severe than the Sensex’s 8.81% fall. Over longer horizons, the stock has delivered impressive gains, with a 55.36% return over three years and a staggering 716.00% over ten years, far outpacing the Sensex’s 15.00% and 178.37% respectively.
Technical Trend Analysis: From Sideways to Mildly Bearish
Poly Medicure’s technical trend has shifted from a sideways pattern to a mildly bearish stance, reflecting a subtle loss of upward momentum. This transition is evident in the daily moving averages, which currently signal a mildly bearish outlook. The stock price is hovering near key moving average levels, and any sustained dip below these could reinforce bearish sentiment.
On the weekly chart, the Moving Average Convergence Divergence (MACD) remains bullish, indicating that medium-term momentum is still positive. However, the monthly MACD has turned bearish, signalling that longer-term momentum is weakening. This divergence between weekly and monthly MACD readings suggests a transitional phase where short-term strength may be offset by longer-term caution.
Momentum Oscillators and Volatility Indicators
The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no definitive signal, hovering in neutral zones without indicating overbought or oversold conditions. This lack of extreme RSI readings implies that the stock is not yet stretched in either direction, leaving room for potential directional moves based on other factors.
Bollinger Bands present a mixed picture: weekly bands are bullish, reflecting price action near the upper band and suggesting upward momentum, while monthly bands are mildly bearish, indicating some pressure on longer-term price stability. This contrast underscores the stock’s current technical indecision.
Additional Technical Indicators: KST, Dow Theory, and OBV
The Know Sure Thing (KST) indicator aligns with the MACD, showing bullish momentum on the weekly chart but bearish signals on the monthly. Dow Theory analysis reveals no clear trend on the weekly scale but a mildly bullish stance monthly, hinting at potential longer-term recovery if short-term hurdles are overcome.
On-Balance Volume (OBV) readings add further nuance. Weekly OBV shows no clear trend, suggesting volume is not decisively supporting price moves in the short term. Conversely, monthly OBV is bullish, indicating accumulation over the longer term, which could provide a foundation for future price appreciation.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Mojo Score and Rating Dynamics
Poly Medicure’s current Mojo Score stands at 34.0, reflecting a Sell grade as of 11 February 2026, upgraded from a previous Strong Sell. This improvement indicates a slight easing of negative sentiment but still advises caution for investors. The small-cap status of the company adds an element of volatility and risk, which is consistent with the mixed technical signals observed.
The upgrade in rating suggests that while the stock remains under pressure, there are emerging signs of stabilisation or potential recovery. Investors should weigh these technical nuances alongside fundamental factors before making decisions.
Comparative Performance and Sector Context
Within the Healthcare Services sector, Poly Medicure’s performance has been relatively resilient, especially over the medium to long term. Its 5-year return of 78.16% significantly outpaces the Sensex’s 48.87%, underscoring the company’s growth credentials despite recent setbacks. However, the recent mildly bearish technical trend and mixed indicator readings suggest that the stock may face headwinds in the near term.
Sector peers and broader market conditions should be monitored closely, as shifts in healthcare demand, regulatory changes, or macroeconomic factors could influence Poly Medicure’s trajectory.
Considering Poly Medicure Ltd? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Investor Takeaway: Navigating Mixed Signals
Poly Medicure Ltd’s technical landscape is characterised by a blend of bullish and bearish indicators across different timeframes. The weekly MACD and KST suggest underlying strength, while monthly counterparts caution of weakening momentum. The absence of clear RSI signals and the mixed Bollinger Bands readings further complicate the outlook.
For investors, this means a cautious approach is warranted. The recent upgrade from Strong Sell to Sell reflects some improvement, but the mildly bearish daily moving averages and monthly technical indicators imply that the stock could face resistance near current levels. Monitoring price action around key moving averages and volume trends will be critical in assessing whether the stock can sustain its recent gains or if a deeper correction is imminent.
Long-term investors may find comfort in the company’s strong historical returns and monthly OBV accumulation, signalling institutional interest. However, short-term traders should remain vigilant for confirmation of trend direction before committing capital.
Overall, Poly Medicure’s technical parameters suggest a stock in transition, with potential for recovery tempered by cautionary signals. A balanced view incorporating both technical and fundamental analysis will best serve investors navigating this evolving scenario.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
